Trevi Therapeutics (TRVI) Other Non-Current Liabilities (2020 - 2022)
Trevi Therapeutics' quarterly Other Non-Current Liabilities came in at $3000.0 in Q4 2022, down 97.37% year-on-year from $114000.0 in Q4 2021, and down 80.0% quarter-over-quarter from $15000.0 in Q3 2022.
Trevi Therapeutics has reported Other Non-Current Liabilities for 3 years, with the latest figure at $3000.0 in Q4 2022.
- For the quarter ending Q4 2022, Other Non-Current Liabilities fell 97.37% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2022 stood at $3000.0 (down 97.37% YoY), and the FY2022 full-year result was $3000.0, down 97.37% from the prior year.
- Other Non-Current Liabilities for Q4 2022 stood at $3000.0, down from $15000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $202000.0 in Q1 2021, with the low at $3000.0 in Q4 2022.
- Average Other Non-Current Liabilities over 3 years is $120600.0, with a median of $143500.0 recorded in 2021.
- Year-over-year, Other Non-Current Liabilities slipped 10.7% in 2021 and tumbled 97.37% in 2022.
- Tracing TRVI's Other Non-Current Liabilities over 3 years: stood at $196000.0 in 2020, then sank by 41.84% to $114000.0 in 2021, then plunged by 97.37% to $3000.0 in 2022.
- The last three Other Non-Current Liabilities figures came in at $3000.0 (Q4 2022), $15000.0 (Q3 2022), and $35000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | 167,000.00 |
| Jun 30, 2021 | 162,000.00 |
| Mar 31, 2021 | 202,000.00 |
| Dec 31, 2020 | 196,000.00 |
| Sep 30, 2020 | 187,000.00 |